Ireland· IE-PA-PA1226/005/003
Vancocin 500 mg powder for concentrate for solution for infusion and powder for oral solution
A vancomycin product containing vancomycin hydrochloride, registered in Ireland by Flynn Pharma Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Vancomycin is registered in 11 of 19 countries.
Countries holding a registration under ATC J01XA01 (vancomycin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Vancomycin · ATC J01XA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of vancomycin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.068 in Finland to $96.70 in Switzerland — a ×1424 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vancomycin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$96.70
- FI Finland$0.068
The record
At a glance
HPRA (Ireland)- Active substance
- VANCOMYCIN HYDROCHLORIDE
- Manufacturer
- Flynn Pharma Limited
- Country
- Ireland (IE)
- ATC code
- J01XA01
- ATC class
- Vancomycin
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1226/005/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
533 interactions on record for vancomycin.
Graded by severity as the source publishes them — 23 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vancomycin · interactions on record
533 records
- 23 severe
- 99 moderate
- 411 info
Most severe, free to view
- PiperacillinJ01CA12severe
- Piperacillin und Beta-Lactamase-InhibitorJ01CR05severe
- CidofovirJ05AB12severe
- Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vancomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVANCOMYCIN APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- United KingdomVancocin 500mg powder for solution for infusion vialsFlynn Pharma Ltd
- FinlandNorimkoNRIM Limited
- BelgiumVamysin 500 mgTeva Pharma Belgium
- PolandEdicinSandoz GmbH
- SwedenVancomycin Bioglan 500 mg Pulver till koncentrat till infusionsvätska, lösningBioglan AB
- SwitzerlandVanco Labatec 500 mg, poudre pour solution à diluer pour perfusionLabatec Pharma SA
- SpainVANCOMICINA MIP 500 MG POLVO PARA SOLUCION PARA PERFUSION EFGMip Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Vancocin, Vancomycin Aptapharma
- Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
- Bulgaria · Vancocin Cp, Ванко-Вм
- Cyprus · Vanco, Vanco Sapiens
- Czechia · Cedepos, Edicin
- Germany · Vanco-Saar, Vancomycin "lederle"
- Denmark · Bactocin, Vancocin
- Estonia · Vancomycin Kabi, Vancosan
- Spain · Vancomicina Mip, Vancomicina Noridem
- Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
- France · Vancomycine Hikma, Vancomycine Kabi
- United Kingdom (Northern Ireland) · Vancocin, Vancocin Matrigel
- Greece · Lyovanco, Vancomycin Noridem
- Croatia · Edicin, Vancomicin Viatris
- Hungary · Vancocin, Vancomycin Aptapharma
- Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Italy · Levovanox, Maxivanil
- Lithuania · Vancomycin Ibe, Vancomycin Kabi
- Luxembourg · Vancomycin Enterocaps, Vancomycine
- Latvia · Vancomycin Kabi, Vancosan
- Malta · Cedepos, Vancomycin Aptapharma
- Netherlands · Vancocin Cp, Vancomycine Fresenius Kabi
- Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Poland · Edicin, Vancomicina Reig Jofre
- Portugal · Vancomicina Azevedos, Vancomicina Generis
- Romania · Cedepos, Vancomicină Aptapharma
- Sweden · Vancocin, Vancomycin Bioglan
- Slovenia · Edicin, Vancomycin Viatris
- Slovakia · Cedepos, Edicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ff36f5c-37f1-4c9e-8793-0a2ad541b1cf GET /v1/drugs/1ff36f5c-37f1-4c9e-8793-0a2ad541b1cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"routes": [
"Intravenous use",
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01XA",
"J01XA01"
],
"strength": null,
"pa_number": "PA1226/005/003",
"substances": [
"VANCOMYCIN HYDROCHLORIDE"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "08/05/1981",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about vancomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.